{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:33Z","timestamp":1772578953658,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.thromres.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T04:46:32Z","timestamp":1348029992000},"page":"72-77","source":"Crossref","is-referenced-by-count":8,"title":["Norethisterone acetate alters coagulation gene expression in vitro in human cell culture"],"prefix":"10.1016","volume":"131","author":[{"given":"Jeanette F.","family":"Brosnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy A.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2012.09.006_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2012.09.006_bb0010","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0049-3848(11)70008-1","article-title":"Post menopausal hormone therapy and venous thromboembolism","volume":"127","author":"Olie","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.09.006_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ebm1079","article-title":"Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in post menopausal women starting treatment within 10 years of the menopause","volume":"15","author":"Harman","year":"2010","journal-title":"Evid Based Med"},{"key":"10.1016\/j.thromres.2012.09.006_bb0020","first-page":"1","article-title":"Cardiovascular health in the post menopausal woman: impact of the timing of hormone replacement therapy","author":"Rosanna","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.thromres.2012.09.006_bb0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Post menopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.09.006_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1160\/TH06-10-0567","article-title":"Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?","volume":"97","author":"Brosnan","year":"2007","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.thromres.2012.09.006_bb0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/gme.0b013e31820eee88","article-title":"Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens","volume":"18","author":"Scarabin","year":"2011","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.thromres.2012.09.006_bb0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.thromres.2012.09.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2011.12.009","article-title":"A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy post menopausal women","author":"Dahm","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.09.006_bb0050","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1160\/TH10-03-0201","article-title":"Genistein alters coagulation gene expression in ovarectomised rats treated with phytoestrogens","volume":"104","author":"Kelly","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.006_bb0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among post menopausal women: impact of route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2012.09.006_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/13697130902905757","article-title":"Different cardiovascular effects of progestins according to structure and activity","volume":"12","author":"Nath","year":"2009","journal-title":"Climacteric"},{"issue":"8","key":"10.1016\/j.thromres.2012.09.006_bb0065","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/138920010794233477","article-title":"Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease","volume":"11","author":"Masood","year":"2010","journal-title":"Curr Drug Metab"},{"issue":"1","key":"10.1016\/j.thromres.2012.09.006_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.12.004","article-title":"Controversies regarding hormone therapy: Insights from inflammation and hemostasis","volume":"70","author":"Koh","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2012.09.006_bb0075","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy hemostatic variables associated with venous thrombosis a randomised, placebo controlled study in post menopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.09.006_bb0080","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1538-7836.2010.03953.x","article-title":"The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy","volume":"8","author":"Bagot","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2012.09.006_bb0085","first-page":"550","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, tPA, PAI and C-reactive protein- a cross sectional population survey","volume":"86","author":"Lowe","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.006_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0083-6729(01)62006-5","article-title":"Transcriptional activation of genes by 17\u03b2-estradiol through estrogen receptor SP-1 interactions","volume":"62","author":"Safe","year":"2001","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1016\/j.thromres.2012.09.006_bb0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.maturitas.2011.10.002","article-title":"Progestogens and venous thromboembolism among postmenopausal women using hormone therapy","volume":"70","author":"Canonico","year":"2011","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.thromres.2012.09.006_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","article-title":"The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives","volume":"103","author":"Norris","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.thromres.2012.09.006_bb0105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/gme.0b013e3181775eca","article-title":"Effect of progestogen and progestogen type on haemostasis measures in post menopausal women: the post menopausal estrogen\/progestin intervention (PEPI) study","volume":"15","author":"Smith","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.thromres.2012.09.006_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.thromres.2011.04.008","article-title":"Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue","volume":"128","author":"Cleuren","year":"2011","journal-title":"Thromb Res"},{"issue":"4\u20136","key":"10.1016\/j.thromres.2012.09.006_bb0115","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0022-4731(87)90199-3","article-title":"Androgen regulation of hepatic gene expression","volume":"27","author":"Roy","year":"1987","journal-title":"J Steroid Biochem"},{"issue":"6","key":"10.1016\/j.thromres.2012.09.006_bb0120","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1210\/endo.132.6.8504742","article-title":"Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists","volume":"132","author":"Kraus","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.thromres.2012.09.006_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2010.09.006","article-title":"Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications","volume":"76","author":"Dressing","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.thromres.2012.09.006_bb0130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.thromres.2012.09.006_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.physiol.66.032802.154710","article-title":"Ligand control of coregulator recruitment to nuclear receptors","volume":"67","author":"Nettles","year":"2005","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"10.1016\/j.thromres.2012.09.006_bb0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.steroids.2005.04.010","article-title":"Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial cells: Evidence of progestogenic effects","volume":"70","author":"Schatz","year":"2005","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.thromres.2012.09.006_bb0145","first-page":"1007","article-title":"Transcriptional regulation of the plasminogen activator inhibitor type 1 with emphasis on negative regulation","volume":"100","author":"Nagamine","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gas011","article-title":"Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1)","author":"Gopal","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.thromres.2012.09.006_bb0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.thromres.2012.09.006_bb0160","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/gme.0b013e3182175e5c","article-title":"Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy","volume":"18","author":"Laliberte","year":"2011","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.thromres.2012.09.006_bb0165","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1210\/jc.2009-0065","article-title":"Progestin and thrombin regulate tissue factor expression in human term decidual cells","volume":"94","author":"Lockwood","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.thromres.2012.09.006_bb0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2004-0857","article-title":"Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1","volume":"90","author":"Kato","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.thromres.2012.09.006_bb0175","first-page":"959","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"issue":"31","key":"10.1016\/j.thromres.2012.09.006_bb0180","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.1016\/S0021-9258(18)51542-8","article-title":"Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma","volume":"264","author":"Novotny","year":"1989","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.thromres.2012.09.006_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jsbmb.2004.12.026","article-title":"Differential effects of estrogens and progestogens on the anticoagulant tissue factor pathway inhibitor in the rat","volume":"94","author":"Shirk","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.thromres.2012.09.006_bb0190","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/ATVBAHA.108.178004","article-title":"Certain progestins prevent the enhancing effect of 17\u03b2-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells","volume":"29","author":"Zer \u2013Fouineau","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.09.006_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-5122(99)00034-1","article-title":"Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple doses to post menopausal women","volume":"33","author":"Stadberg","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.thromres.2012.09.006_bb0200","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/009127002401382740","article-title":"Evaluation of the bioequivalence of two 7 day 17beta-estradiol transdermal delivery systems by anatomical site","volume":"42","author":"Harison","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.thromres.2012.09.006_bb0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jcem-62-4-761","article-title":"Enhanced hepatic extraction of estrogens used for replacement therapy","volume":"62","author":"Steingold","year":"1986","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812007189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812007189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:27:38Z","timestamp":1643452058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812007189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0049384812007189"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.09.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}